home / openregs / federal_register

federal_register: 2012-28142

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2012-28142 International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Q11 Development and Manufacture of Drug Substances." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance describes approaches to developing and understanding the manufacturing process of a drug substance and provides guidance on what information should be provided in certain sections of the Common Technical Document (CTD). The guidance is intended to harmonize the scientific and technical principles relating to the description and justification of the development and manufacturing process of drug substances (both chemical entities and biotechnological/biological entities) to enable a consistent approach for providing and evaluating this information across the three regions. The discussion of principles in the guidance is intended to apply only to the manufacture of drug substance, not the manufacture of finished drug products. 2012-11-20 2012 11 https://www.federalregister.gov/documents/2012/11/20/2012-28142/international-conference-on-harmonisation-guidance-on-q11-development-and-manufacture-of-drug https://www.govinfo.gov/content/pkg/FR-2012-11-20/pdf/2012-28142.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Q11 Development and Manufacture of Drug Substances." The guidance was prepared under the auspices of the International Conference on Harmonisation of...

Links from other tables

  • 2 rows from document_number in federal_register_agencies
  • 1 row from fr_document_number in fr_regs_crossref
Powered by Datasette · Queries took 1.372ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API